TrialTrials2014

Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study.

Paul Gillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.